Fair Pricing Coalition Sign-on Letter to Gilead on Pricing of TAF
Letter signed by a number of organizations and individuals urging Gilead to consider drug pricing that addresses the need for cost-contained HIV care delivery in the U.S.
Town Hall Meeting to Discuss Drastic Cuts to City’s HIV Testing and STD Screening Programs
In response to disturbing trends in New York City’s response to the ongoing HIV and STD epidemics, ACT UP\New York and Treatment Action Group (TAG) will host a town hall meeting at the New York City
2015 Pipeline Report
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development.
Toward Comprehensive HIV Prevention Service Delivery in the United States: An Action Plan
An objective of the National HIV/AIDS Strategy (NHAS), released by the White House in July 2010, is to lower the annual number of new infections in the United States by 25 percent by the end of 2015.
NYTimes OP-Ed: Don’t Weaken the F.D.A.’s Drug Approval Process
An Op-Ed written by Gregg Gonsalves, Mark Harrington, and David A. Kessler.
Story: Gilead Sciences May Have Found A Cure For HIV
May 2015 Examples of media coverage: Gilead Sciences (GILD) May Have Found A Cure For HIV! – CNA Finance, May 18, 2015 This Experimental Drug Could Finally Cure HIV – Motley Fool, May 18, 2015 Original source: Unknown, possibly a…
Governor Releases Blueprint to End AIDS in NYS by 2020
New York, NY– Governor Cuomo formally accepted the long-awaited Blueprint to End AIDS at a public event on Wednesday, marking an important step towards fulfilling his commitment to end AIDS in New York State.
Governor Cuomo’s Plan to End AIDS Will Save Lives and Money
TAG & Housing Works Report Shows Plan To End AIDS By 2020 Will Translate Into $4.5 Billion In Net Medicaid Savings For NY State.
An HIV Cure and a Vaccine within the Next 15 Years?
Optimism is not without merit, but the science remains incredibly fragile By Richard Jefferys We’re pretty optimistic in this 15-year period we will get those two new tools. —Bill Gates, World Economic Forum, January 23, 2015 Earlier this year, Bill…
Toward an Ambitious National HIV/AIDS Strategy
We won’t end HIV as an epidemic with anemic goals, delayed surveillance data, feeble support of state policies and resource needs, and an inadequate implementation science agenda By Kenyon Farrow The U.S. National HIV/AIDS Strategy (NHAS) ends its five-year run…